Kallikrein 11 (KLK11) (Middle Region) Peptide
-
- Target See all Kallikrein 11 (KLK11) products
- Kallikrein 11 (KLK11)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- NLQKEEGCEQ TRTATESFPH PGFNNSLPNK DHRNDIMLVK MASPVSITWA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KLK11 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Kallikrein 11 (KLK11)
- Synonyms
- KLK11 Peptide, 2310015I08Rik Peptide, Prss20 Peptide, TLSP Peptide, PRSS20 Peptide, kallikrein related peptidase 11 Peptide, kallikrein related-peptidase 11 Peptide, kallikrein-related peptidase 11 Peptide, KLK11 Peptide, Klk11 Peptide
- Background
-
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Alternate splicing of this gene results in multiple transcript variants encoding distinct isoforms which are differentially expressed.
Alias Symbols: TLSP, PRSS20
Protein Size: 250 - Gene ID
- 11012
- NCBI Accession
- NM_001136032, NP_001129504
-